Daiichi Sankyo
Aggregated from S&P 500 earnings calls
Total Mentions
3
Companies
1
Sentiment
BULLISH 1
Mentions by Company
Merck & Co. Inc.Q3-2025
3×BULLISH
“$170 million of income recognized in 2024 related to a payment received from Daiichi Sankyo associated with the expansion of an existing agreement”
“Phase 2/3 REJOICE-Ovarian01 trial in collaboration with Daiichi Sankyo in certain types of platinum-resistant ovarian cancer”